Samir Parekh, MBBS

In this segment the panelists, Dr. Samir Parekh and Dr. Saurabh Mehandru, of Mount Sinai in New York, work through the diagnostic approach to persistent diarrhea after chimeric antigen receptor (CAR) T-cell therapy for relapsed multiple myeloma.

In this segment the panelists, Dr. Samir Parekh and Dr. Saurabh Mehandru, both of Mount Sinai in New York, open their discussion of gastrointestinal toxicity following anti-B-cell maturation antigen chimeric antigen receptor (CAR) T-cell therapy for relapsed multiple myeloma.

Samir Parekh, MBBS, discusses using genomics to treat patients with multiple myeloma.

Samir Parekh, MBBS, associate professor of medicine, Hematology/Oncology, Mount Sinai Hospital, discusses the evolving treatment landscape in myeloma.